Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx

Atsushi Obata, Masao Eura, Jiichiro Sasaki, Hideyuki Saya, Kazuaki Chikamatsu, Mitsuhiro Tada, Richard D. Iggo, Eiji Yumoto

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

We examined the frequency of p53 mutations in 38 oropharyngeal squamous cell carcinomas (SCC), using both a yeast functional assay and a conventional immunohistochemical staining method (IHC) to detect p53 mutations. We also explored the clinical importance of p53 mutations in oropharyngeal SCC. An accumulation of p53 protein was detected in 17 of the 38 (45%) tumors by IHC, whereas the yeast-based assay detected 6 additional p53 mutations, for a total of 23 tumors (61%) with p53 mutations. The cDNA sequencing analysis revealed that the 6 mutations undetected by IHC consisted of 3 frameshift, 1 nonsense and 2 missense mutations. Thus, the yeast functional assay was more sensitive than conventional IHC for detecting p53 mutations. Subsequently, the relationship between p53 mutations and the clinico-pathological parameters in oropharyngeal SCC was evaluated using the results of the functional assay. Mutation of p53 was not associated with the patient age, sex, tumor stage or degree of tumor cell differentiation. Interestingly, heavy drinking had a significant positive correlation with the p53 mutation, but heavy smoking did not, suggesting that prolonged exposure to alcohol is more related to p53 mutation in oropharyngeal SCC than to tobacco consumption. Radiation sensitivity was examined by comparing tumor size on magnetic resonance images before and after completion of therapy with 45 Gy radiation, in the 18 cases of T2 oropharyngeal SCC that were initially treated by radiotherapy. The results showed that tumors with wild-type p53 decreased in size significantly compared to those with mutant p53. In 33 patients treated with curative intent, the overall survival after the completion of therapy was better in patients with a wild-type p53 tumor than in patients with a mutant p53 tumor. We conclude that p53 mutation is associated with radiation resistance and a decreased probability of survival in oropharyngeal SCC. (C) 2000 Wiley-Liss. Inc.

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalInternational Journal of Cancer
Volume86
Issue number3
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Oropharynx
Squamous Cell Carcinoma
Mutation
Neoplasms
Yeasts
Radiation Dosage
Survival
Radiation Tolerance
Tobacco Use
Mutation Rate
Missense Mutation
Drinking
Cell Differentiation
Magnetic Resonance Spectroscopy
Radiotherapy
Complementary DNA
Smoking
Alcohols
Radiation
Staining and Labeling

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Obata, A., Eura, M., Sasaki, J., Saya, H., Chikamatsu, K., Tada, M., ... Yumoto, E. (2000). Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. International Journal of Cancer, 86(3), 187-193.

Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. / Obata, Atsushi; Eura, Masao; Sasaki, Jiichiro; Saya, Hideyuki; Chikamatsu, Kazuaki; Tada, Mitsuhiro; Iggo, Richard D.; Yumoto, Eiji.

In: International Journal of Cancer, Vol. 86, No. 3, 2000, p. 187-193.

Research output: Contribution to journalArticle

Obata, A, Eura, M, Sasaki, J, Saya, H, Chikamatsu, K, Tada, M, Iggo, RD & Yumoto, E 2000, 'Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx', International Journal of Cancer, vol. 86, no. 3, pp. 187-193.
Obata, Atsushi ; Eura, Masao ; Sasaki, Jiichiro ; Saya, Hideyuki ; Chikamatsu, Kazuaki ; Tada, Mitsuhiro ; Iggo, Richard D. ; Yumoto, Eiji. / Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. In: International Journal of Cancer. 2000 ; Vol. 86, No. 3. pp. 187-193.
@article{9e27c9c490b848a5b2d9bcc518ee7cb8,
title = "Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx",
abstract = "We examined the frequency of p53 mutations in 38 oropharyngeal squamous cell carcinomas (SCC), using both a yeast functional assay and a conventional immunohistochemical staining method (IHC) to detect p53 mutations. We also explored the clinical importance of p53 mutations in oropharyngeal SCC. An accumulation of p53 protein was detected in 17 of the 38 (45{\%}) tumors by IHC, whereas the yeast-based assay detected 6 additional p53 mutations, for a total of 23 tumors (61{\%}) with p53 mutations. The cDNA sequencing analysis revealed that the 6 mutations undetected by IHC consisted of 3 frameshift, 1 nonsense and 2 missense mutations. Thus, the yeast functional assay was more sensitive than conventional IHC for detecting p53 mutations. Subsequently, the relationship between p53 mutations and the clinico-pathological parameters in oropharyngeal SCC was evaluated using the results of the functional assay. Mutation of p53 was not associated with the patient age, sex, tumor stage or degree of tumor cell differentiation. Interestingly, heavy drinking had a significant positive correlation with the p53 mutation, but heavy smoking did not, suggesting that prolonged exposure to alcohol is more related to p53 mutation in oropharyngeal SCC than to tobacco consumption. Radiation sensitivity was examined by comparing tumor size on magnetic resonance images before and after completion of therapy with 45 Gy radiation, in the 18 cases of T2 oropharyngeal SCC that were initially treated by radiotherapy. The results showed that tumors with wild-type p53 decreased in size significantly compared to those with mutant p53. In 33 patients treated with curative intent, the overall survival after the completion of therapy was better in patients with a wild-type p53 tumor than in patients with a mutant p53 tumor. We conclude that p53 mutation is associated with radiation resistance and a decreased probability of survival in oropharyngeal SCC. (C) 2000 Wiley-Liss. Inc.",
author = "Atsushi Obata and Masao Eura and Jiichiro Sasaki and Hideyuki Saya and Kazuaki Chikamatsu and Mitsuhiro Tada and Iggo, {Richard D.} and Eiji Yumoto",
year = "2000",
language = "English",
volume = "86",
pages = "187--193",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx

AU - Obata, Atsushi

AU - Eura, Masao

AU - Sasaki, Jiichiro

AU - Saya, Hideyuki

AU - Chikamatsu, Kazuaki

AU - Tada, Mitsuhiro

AU - Iggo, Richard D.

AU - Yumoto, Eiji

PY - 2000

Y1 - 2000

N2 - We examined the frequency of p53 mutations in 38 oropharyngeal squamous cell carcinomas (SCC), using both a yeast functional assay and a conventional immunohistochemical staining method (IHC) to detect p53 mutations. We also explored the clinical importance of p53 mutations in oropharyngeal SCC. An accumulation of p53 protein was detected in 17 of the 38 (45%) tumors by IHC, whereas the yeast-based assay detected 6 additional p53 mutations, for a total of 23 tumors (61%) with p53 mutations. The cDNA sequencing analysis revealed that the 6 mutations undetected by IHC consisted of 3 frameshift, 1 nonsense and 2 missense mutations. Thus, the yeast functional assay was more sensitive than conventional IHC for detecting p53 mutations. Subsequently, the relationship between p53 mutations and the clinico-pathological parameters in oropharyngeal SCC was evaluated using the results of the functional assay. Mutation of p53 was not associated with the patient age, sex, tumor stage or degree of tumor cell differentiation. Interestingly, heavy drinking had a significant positive correlation with the p53 mutation, but heavy smoking did not, suggesting that prolonged exposure to alcohol is more related to p53 mutation in oropharyngeal SCC than to tobacco consumption. Radiation sensitivity was examined by comparing tumor size on magnetic resonance images before and after completion of therapy with 45 Gy radiation, in the 18 cases of T2 oropharyngeal SCC that were initially treated by radiotherapy. The results showed that tumors with wild-type p53 decreased in size significantly compared to those with mutant p53. In 33 patients treated with curative intent, the overall survival after the completion of therapy was better in patients with a wild-type p53 tumor than in patients with a mutant p53 tumor. We conclude that p53 mutation is associated with radiation resistance and a decreased probability of survival in oropharyngeal SCC. (C) 2000 Wiley-Liss. Inc.

AB - We examined the frequency of p53 mutations in 38 oropharyngeal squamous cell carcinomas (SCC), using both a yeast functional assay and a conventional immunohistochemical staining method (IHC) to detect p53 mutations. We also explored the clinical importance of p53 mutations in oropharyngeal SCC. An accumulation of p53 protein was detected in 17 of the 38 (45%) tumors by IHC, whereas the yeast-based assay detected 6 additional p53 mutations, for a total of 23 tumors (61%) with p53 mutations. The cDNA sequencing analysis revealed that the 6 mutations undetected by IHC consisted of 3 frameshift, 1 nonsense and 2 missense mutations. Thus, the yeast functional assay was more sensitive than conventional IHC for detecting p53 mutations. Subsequently, the relationship between p53 mutations and the clinico-pathological parameters in oropharyngeal SCC was evaluated using the results of the functional assay. Mutation of p53 was not associated with the patient age, sex, tumor stage or degree of tumor cell differentiation. Interestingly, heavy drinking had a significant positive correlation with the p53 mutation, but heavy smoking did not, suggesting that prolonged exposure to alcohol is more related to p53 mutation in oropharyngeal SCC than to tobacco consumption. Radiation sensitivity was examined by comparing tumor size on magnetic resonance images before and after completion of therapy with 45 Gy radiation, in the 18 cases of T2 oropharyngeal SCC that were initially treated by radiotherapy. The results showed that tumors with wild-type p53 decreased in size significantly compared to those with mutant p53. In 33 patients treated with curative intent, the overall survival after the completion of therapy was better in patients with a wild-type p53 tumor than in patients with a mutant p53 tumor. We conclude that p53 mutation is associated with radiation resistance and a decreased probability of survival in oropharyngeal SCC. (C) 2000 Wiley-Liss. Inc.

UR - http://www.scopus.com/inward/record.url?scp=0034688905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034688905&partnerID=8YFLogxK

M3 - Article

C2 - 10754498

AN - SCOPUS:0034688905

VL - 86

SP - 187

EP - 193

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -